| Clinical utility of CA-125 in the management of uterine carcinosarcoma |
|
Matsuo, Koji
(Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California)
Ross, Malcolm S. (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Magee-Womens Hospital, University of Pittsburgh) Yunokawa, Mayu (Department of Breast and Medical Oncology, National Cancer Center Hospital) Johnson, Marian S. (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky) Machida, Hiroko (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California) Omatsu, Kohei (Department of Gynecology, Cancer Institute Hospital) Klobocista, Merieme M. (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Albert Einstein College of Medicine, Montefiore Medical Center) Im, Dwight D. (The Gynecologic Oncology Center, Mercy Medical Center) Satoh, Shinya (Department of Obstetrics and Gynecology, Tottori University) Baba, Tsukasa (Department of Obstetrics and Gynecology, Kyoto University) Ikeda, Yuji (Department of Obstetrics and Gynecology, The University of Tokyo) Bush, Stephen H. (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Moffitt Cancer Center, University of South Florida) Hasegawa, Kosei (Department of Obstetrics and Gynecology, Saitama Medical University International Medical Center) Blake, Erin A. (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado) Takekuma, Munetaka (Department of Gynecology, Shizuoka Cancer Center) Shida, Masako (Department of Obstetrics and Gynecology, Tokai University) Nishimura, Masato (Department of Obstetrics and Gynecology, Tokushima University) Adachi, Sosuke (Department of Obstetrics and Gynecology, Niigata University) Pejovic, Tanja (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Oregon Health & Science University) Takeuchi, Satoshi (Department of Obstetrics and Gynecology, Iwate Medical University) Yokoyama, Takuhei (Department of Obstetrics and Gynecology, Osaka Rosai Hospital) Ueda, Yutaka (Department of Obstetrics and Gynecology, Osaka University) Iwasaki, Keita (Department of Obstetrics and Gynecology, Aichi Medical University) Miyake, Takahito M. (Department of Obstetrics and Gynecology, Kawasaki Medical School) Yanai, Shiori (Department of Obstetrics and Gynecology, Kurashiki Medical Center) Nagano, Tadayoshi (Department of Obstetrics and Gynecology, Kitano Hospital) Takano, Tadao (Department of Obstetrics and Gynecology, Tohoku University) Shahzad, Mian MK (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Moffitt Cancer Center, University of South Florida) Ueland, Frederick R. (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky) Kelley, Joseph L. (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Magee-Womens Hospital, University of Pittsburgh) Roman, Lynda D. (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California) |
| 1 | Cantrell LA, Blank SV, Duska LR. Uterine carcinosarcoma: a review of the literature. Gynecol Oncol 2015;137:581-8. DOI |
| 2 | Matsuo K, Ross MS, Machida H, Blake EA, Roman LD. Trends of uterine carcinosarcoma in the United States. J Gynecol Oncol 2018;29:e22. DOI |
| 3 | Cherniack AD, Shen H, Walter V, Stewart C, Murray BA, Bowlby R, et al. Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell 2017;31:411-23. DOI |
| 4 | Matsuo K, Takazawa Y, Ross MS, Elishaev E, Podzielinski I, Yunokawa M, et al. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma. Ann Oncol 2016;27:1257-66. DOI |
| 5 | Matsuo K, Omatsu K, Ross MS, Johnson MS, Yunokawa M, Klobocista MM, et al. Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma. Gynecol Oncol 2017;145:78-87. |
| 6 | Das S, Batra SK. Understanding the unique attributes of MUC16 (CA125): potential implications in targeted therapy. Cancer Res 2015;75:4669-74. DOI |
| 7 | Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers 2016;2:16061. DOI |
| 8 | Huang GS, Chiu LG, Gebb JS, Gunter MJ, Sukumvanich P, Goldberg GL, et al. Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma. Gynecol Oncol 2007;107:513-7. DOI |
| 9 | Thomakos N, Rodolakis A, Zagouri F, Zacharakis D, Sotiropoulou M, Akrivos N, et al. Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas? Arch Gynecol Obstet 2013;287:97-102. DOI |
| 10 | Harano K, Hirakawa A, Yunokawa M, Nakamura T, Satoh T, Nishikawa T, et al. Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group. Int J Clin Oncol 2016;21:168-76. DOI |
| 11 | Mohebtash M, Tsang KY, Madan RA, Huen NY, Poole DJ, Jochems C, et al. A pilot study of MUC-1/CEA/TRICOM poxviral-based vaccine in patients with metastatic breast and ovarian cancer. Clin Cancer Res 2011;17:7164-73. DOI |
| 12 | Matsuo K, Johnson MS, Im DD, Ross MS, Bush SH, Yunokawa M, et al. Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery. J Surg Oncol 2018;117:488-96. DOI |
| 13 | Salani R, Khanna N, Frimer M, Bristow RE, Chen LM. An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. Gynecol Oncol 2017;146:3-10. DOI |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
